Strides Pharma arm SPIAG inks $12 million deal to acquire Sandoz generics portfolio in Africa

107 0

Strides Pharma International AG (SPIAG), a step-down subsidiary of Strides Pharma Science Limited, has signed an agreement for the acquisition and in-licensing of a portfolio of branded generic produ… [+1310 chars]
Read Full Story

Related Post